Hayya Life Science
↗Jakarta, Indonesia
Hayya Life Science is an Indonesian-based Contract Research Organization (CRO) and Site Management Organization (SMO) established in 2013. The company provides a full spectrum of clinical research services, including clinical trial management, site management, project management, medical writing, regulatory affairs, and data management. It serves as a critical local partner for international pharmaceutical and biotech companies looking to conduct clinical trials or register products in the Indonesian market.
As a specialized service provider, Hayya Life Science has extensive experience in managing therapeutic areas such as oncology, cardiovascular disease, respiratory disease, and infectious diseases. The company is particularly noted for its involvement in vaccine studies and its expertise in navigating the complex regulatory environment of Indonesia's BPOM (National Agency of Drug and Food Control).
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:CRO
Sub-Industry:Clinical Research and Regulatory Services
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Private
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Vaccines, Biologics
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Tigermed Corp (Global CRO collaboration), Intellim (Japanese CRO partnership for SOP and trial management), Shionogi (Clinical study support)
COMPETITION
Position:Niche Player
Competitors:Prodia The CRO, Equilab International, PT Pharma Metric Labs, IQVIA Indonesia, Parexel Indonesia
LEADERSHIP
Key Executives:
Dr. Ade Irma Yoeticia - CEO
Dr. Paula Melverina - Operational Director
Scientific Founders:Dr. Ade Irma Yoeticia
LINKS
Website:hayyalifescience.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Hayya Life Science. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.